28th – 29th November 2017, London, UK
Ophthalmic Drugs will gather industry leaders to discuss the latest challenges and changes in the field of ophthalmology. Explore novel approaches to treatment, ocular medical devices, targeted drug delivery technology and real-life challenges to pre-clinical and clinical trials, to deepen your understanding of inherited ocular diseases.
2nd - 3rd November, 2017, London, UK
The Global Clinical Connect 2017 (GCC’17) conference focuses on introducing pioneer technology, developing better patient engagement and collaborating strategies in clinical trials. With the right commitment and attention to detail, contract research organizations (CROs) and pharmaceutical companies can drive collaboration with greater efficiency.
9th - 10th August, 2017, Minneapolis, MN, USA
The 3rd Annual Human Factors Excellence for Medical Device Design conference will engage with leading practitioners to share relevant techniques to improve human factors in Medical Device design in order to decrease user-related risk and develop safer products.
15-16 November 2017, Iselin, New Jersey
Building on the success of previous events, SMi proudly announces the return of its 4th annual Biosimilars North America Conference, taking place on November 15 and 16, 2017 in Iselin, New Jersey.
27th & 28th September, London UK
As the patents for several innovator biologics expire, biopharmaceutical companies are taking the opportunity to develop more affordable forms creating a rapidly booming biosimilars market. However, as the field of biosimilars evolves, challenges in immunogenicity studies, securing market share, exclusivity and regulations still persist.
6-7 September 2017, in London, UK
Increasing consumer consciousness towards health and personal care coupled with rising trend for nutraceutical products are expected to fuel the growth of Collagen. Improving standard of living and growing fitness consciousness are likely to be the key drivers to propel demand. Global collagen market size was valued at more than USD 3 billion in 2015 and is likely to exceed USD 5 billion by 2023, growing at a CAGR of more than 7% from 2016 to 2023.
